ESPN reports on new ACL repair study

Taubman Emerging Scholar Asheesh Bedi, M.D., partners in clinical trail funded by billionaire Mark Cuban

Funding from the Mark Cuban Foundation, run by the well-known owner of the Dallas Mavericks, will allow University of Michigan scientists and physicians to study how human growth hormone may aid recovery from an ACL tear – one of the most frequent, traumatic and dreaded knee injuries among athletes.

Despite advances in surgical techniques and accelerated rehabilitation, the nearly quarter of a million patients who suffer ACL tears each year still experience permanent weakness and muscle loss. This weakness largely limits their ability to return to the same level of sport performance, and can increase their chances of developing painful osteoarthritis later in life.

The clinical trial that opened in 2015 will study if growth hormone can safely improve recovery and help to prevent long-term osteoarthritis and knee joint weakness after an ACL tear.

Read the ESPN article featuring Taubman Emerging Scholar Asheesh Bedi, MD, one of the trial's investigators.  Dr. Bedi is the Harold and Helen W. Gehring Early Career Professor of Orthopaedic Surgery and an Assistant Professor of Sports Medicine and Shoulder Surgery at the University of Michigan and MedSport Program.

 

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift